An observational study in Low Back Pain, sponsored by Istituti Clinici Scientifici Maugeri SpA. Recruiting at 2 sites in Italy. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-02-17.
Sponsored by Istituti Clinici Scientifici Maugeri SpA · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 56 studies in Low Back Pain with a site in Italy — 12 open to participants now, 13 under way, 1 of them phase 3. Low Back Pain · Italy.
Among the 56 studies in Low Back Pain with a site in Italy, this one is the 7th largest by planned enrollment of the 15 observational ones that give a count, is one of 2 that started in 2024, is one of 16 observational ones, reaches primary completion later than 9 of the 12 other live ones, and was the 52nd registered.
2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.
Browse Low Back Pain studies →12 of the 56 studies in Low Back Pain with a site in Italy are open now. Recruiting first, the newest first:
Manusapiens · Sites in Italy
Ages 20–40 · Women only · Healthy volunteers
Fondazione Don Carlo Gnocchi Onlus · Sites in Italy
Ages 18+
International Institute of Behavioral Medicines · Sites in Italy
Ages 11–30
International Institute of Behavioral Medicines · Sites in Italy
Ages 18+
Campus Bio-Medico University · Sites in Italy
Ages 18+
A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →
Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.
This study: 18 Years to 90 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
56 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 6 · Phase 3 5 · Phase 4 7
First in 2005; this study’s year is marked. 2 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 115 is above the median of 100 across 484 observational studies indexed under Low Back Pain.
Median enrollment 67 across the 40 interventional studies, 104 across the 15 observational. Of the 34 that completed or were terminated, 4 (12%) have results posted.
This tab as a report to print or save as PDF → With an account.
13 of 56 have an industry lead sponsor. The 10 most frequent:
Istituti Clinici Scientifici Maugeri SpA is the lead sponsor of 128 studies on the registry; 52 are open to participants now.
Istituti Clinici Scientifici Maugeri SpA has 2 studies filed under Low Back Pain — fewer than ten, so there is no comparison to draw.
2 of the studies in Low Back Pain with a site in Italy that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07568353G. d'Annunzio UniversityBrain Connectivity and Perceptive Surfaces in Chronic Low Back Pain (SUPER-RMNf) | 2027-05-31 |
| NCT07647757Federico II UniversityNeurolyser XR for the Treatment of Sacroiliitis | 2027-07 |
Add all 2 to your calendar (.ics) → With an account.
Among the 56 studies in Low Back Pain with a site in Italy, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This prospective observational study aims to develop and validate an Italian version of the Waddell Disability Index (WDI-I), a self-administered questionnaire designed to assess disability related to chronic low back pain. Low back pain is a leading cause of disability worldwide, and patient-reported outcome measures are increasingly recognized as essential tools for comprehensive clinical assessment and rehabilitation planning.
The study involves a standardized cross-cultural translation process, including forward and backward translations by bilingual translators and review by a panel of expert clinicians, followed by pilot testing. After consensus, the finalized Italian version (WDI-I) will undergo psychometric validation.
A total of 115 adult patients with chronic low back pain (≥3 months) will be recruited from two rehabilitation centers. At baseline, participants will complete the WDI-I along with the Numeric Pain Rating Scale (NPRS), the Italian Oswestry Disability Index (ODI-I), and the Italian Pain Catastrophizing Scale (PCS-I). The WDI-I will be re-administered after 7-10 days to assess test-retest reliability.
The primary endpoints are internal consistency, reliability, and construct validity of the WDI-I. Statistical analyses will include Cronbach's alpha and item-total correlations for internal consistency, intraclass correlation coefficients (ICC), standard error of measurement (SEM), and minimum detectable change (MDC) for reliability, and Spearman correlation coefficients to evaluate concurrent validity with established pain and disability measures.
The study seeks to provide a reliable and valid Italian instrument for assessing disability in individuals with chronic low back pain, facilitating both clinical practice and research
Rationale Low back pain is a very common condition and represents the leading cause of disability in industrialized countries, with a substantial economic and social impact.
The assessment of individuals with low back pain can be performed using physical tests (e.g., joint mobility, strength, gait) and outcome measures that evaluate pain intensity, functional limitations during daily activities, and quality of life. Over time, these latter measures have demonstrated strong reliability and validity, in some cases even surpassing the reliability and validity of physical tests. There is a growing consensus in the literature that such outcome measures, often self-completed by patients, represent an important complement to the overall assessment of individuals with low back pain and support the planning of rehabilitation programs. However, these measures are still viewed with some reluctance by healthcare professionals, despite not requiring additional assessment time and instead providing valuable supplementary information.
In this context, an outcome measure known as the Waddell Disability Index (WDI) exists. It was published in 1984 in the international journal Spine by Gordon Waddell and Chris Main and consists of a self-administered questionnaire including several activities of daily living, excluding work- and sport-related activities. The questionnaire is simple to administer and requires approximately five minutes to complete.
Considering the epidemiological background, the need for appropriate assessment tools, and the absence of a culturally adapted Italian version of the WDI, it is considered useful to develop an Italian adaptation of the WDI in individuals with low back pain and to analyze its reliability and validity properties.
Objectives The objective of this study is to produce an Italian-language version of the WDI through a cross-cultural translation procedure and to validate it in terms of internal consistency, reliability, and validity in a population of patients with chronic low back pain.
Endpoints
To demonstrate that the Italian version of the WDI is internally consistent, reliable, and correlated with the following scales:
Population Patients A total of 115 patients referred to the Istituti Clinici Scientifici Maugeri for outpatient medical evaluation for chronic low back pain will be enrolled.
65 patients will be recruited from the Neuromotor Rehabilitation Unit of the Scientific Institute of Tradate 50 patients will be recruited from the Neuromotor Rehabilitation Unit of the Scientific Institute of Lissone
Inclusion Criteria
Exclusion Criteria
Translators Two native English-speaking translators One Italian language teacher (voluntary contribution)
Study Design An Italian-language version of the questionnaire will be developed through a standardized procedure involving translators and a group of five experienced clinicians.
Initially, each clinician independently produces a translated version of the scale together with the Italian-speaking translator. A synthesis process then leads to a single translated version, which is submitted to the two native English-speaking translators, each of whom performs a back-translation. The equivalence between the back-translations and the original version is then verified.
The resulting version is pilot-tested in an initial group of 15 patients (three patients per clinician).
After confirming applicability and reaching consensus, the final version (WDI-I) is defined.
At the two institutes (Tradate and Lissone), 50 patients each will be included in the final validation study, accounting for an expected dropout rate of 10%.
At time point T0, the following assessments are collected in a single session:
Type of Study Prospective observational study
Sample Size The sample size was determined based on standard practice, as no formal sample size calculation exists for validation studies. Ten patients per item were recruited, with an additional 10% to account for possible dropouts. An extra 15 patients were included for the pilot study, resulting in a total of 115 patients.
Collected Variables
Data Monitoring and Collection A dedicated data collection form will be prepared for each patient, including demographic and clinical data as well as the results of the clinical scales specified in the protocol.
Patient data will be pseudonymized and processed in accordance with Article 13 of EU Regulation 2016/679 (GDPR).
Statistical Analysis Methods
The statistical methods used to analyze the psychometric properties of the WDI-I include:
-Internal Consistency Internal consistency (the extent to which items measure the same construct) will be calculated using Cronbach's alpha and item-total correlations.
α > 0.90 is considered excellent (values > 0.95 may indicate item redundancy), α between 0.80-0.89 is considered good, and α between 0.70-0.79 is acceptable.
Item-total correlation assesses how well each item correlates with the total score, excluding that item. A minimum acceptable value of 0.40 is used.
Reliability Analysis Test-retest reliability will be evaluated to assess the stability of WDI-I scores across two administrations. The Intraclass Correlation Coefficient (ICC; two-way random, absolute agreement) with a 95% confidence interval will be calculated.
Agreement analysis, reflecting absolute measurement error, will include:
Validity Analysis Construct validity will be assessed by examining correlations with other concurrently administered measures. Concurrent validity will be quantified using Spearman's rank correlation coefficient between WDI-I scores and NPRS, ODI-I, and PCS-I scores.
Correlation coefficients will be interpreted as: 0.75: excellent; 0.50-0.75: moderate to good; 0.25-0.50: fair.
Patients referred to the Istituti Clinici Scientifici Maugeri for outpatient medical evaluation for chronic low back pain will be enrolled
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients with chronic low back pain (≥3 months)
Internal consistency
Internal consistency is a measure of how well the items (questions) within a questionnaire work together to assess the same underlying construct or concept. It will be measured with Cronbach's alpha and item-total correlation.
Time frame: Through study completion, an average of 1 year
Reliability
Reliability is the extent to which an instrument yields the same results when measurements are repeated under identical or similar conditions
Time frame: Through study completion, an average of 1 year
Construct Validity
Construct validity refers to the extent to which a questionnaire actually measures the theoretical construct it is intended to measure. It reflects how well the instrument aligns with theoretical expectations.
Time frame: Through study completion, an average of 1 year
Started Dec 2024 (actual). Primary completion is estimated for Jul 2026, 19 months after the start.
Of 177 non-industry observational studies under Low Back Pain, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 48. This study's planned 19 months is below that.
Counting every sponsor, half of 187 studies reached it within 24 months; a quarter within 10 and three quarters within 48.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Istituti Clinici Scientifici Maugeri SpA →